Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

VERTEX PHARMACEUTICALS

Filed by TIBER CREEK GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$80,000.00
Expenses
Not reported
Filing UUID
4134ce21-7614-4c26-951e-4af8ba563c4d
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.

Literal federal measure citations: H.R. 1227, S. 475

DEF · Defense

Issues related to opioid alternatives; Issues related to H.R. 3838 - SPEED Act; Issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Literal federal measure citations: H.R. 3838, S. 2296

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.